Insiders who reported open-market trades in the last 12 months at the companies Eric M. Dube files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Peter Heerma - $18.77M in TVTX purchases and sales in the last 12 months
William E. Rote - $14.02M in TVTX purchases and sales in the last 12 months
Elizabeth E. Reed - $7.02M in TVTX purchases and sales in the last 12 months
Eric M. Dube is a corporate insider, tracked as CHIEF EXECUTIVE OFFICER, Director of Travere Therapeutics, Inc. (TVTX). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Eric M. Dube submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Eric M. Dube been buying or selling stock?
Recorded transactions: 0 open-market purchases and 21 open-market sales ($41.35M) across all tracked filings.
Eric M. Dube is CHIEF EXECUTIVE OFFICER, Director of Travere Therapeutics, Inc. (TVTX). 8 SEC Form 4 filings on record going back to 2025, most recently on 18 September 2026. Most recent open-market trade: sold $442K of TVTX on 18 September 2026. Lifetime open-market sales: $41.35M.
Recent transactions
20
The latest 20 SEC Form 4 transactions reported by Eric M. Dube.
InsiderAlpha's records for Eric M. Dube go back to 2025: 8 primary Form 4 filings, an average of 4.0 per year. 45 recorded transactions carry a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
